See also this year's filing and all EDGAR filings for this company.
PDF Report 0001114220_2014_Keryx_Biopharmaceuticals_INC.pdf
Logs
| warning | The stock price does not exist | industry.us_generic | {} |
| warning | Missing logo | subcommand.report | {} |
Graph
Absolute values for 0001114220, Keryx Biopharmaceuticals INC
| xvar | xval | |
|---|---|---|
| 0 | AssetsCurrent | 56,928,000 |
| 1 | IntangibleAssetsNetIncludingGoodwill | 3,208,000 |
| 2 | PropertyPlantAndEquipmentNet | 349,000 |
| 3 | remainder_Assets | 281,000 |
| 4 | LiabilitiesCurrent | 15,328,000 |
| 5 | LiabilitiesNoncurrent | 38,000 |
| 6 | remainder_Liabilities | 0 |
| 7 | CostOfGoodsAndServicesSold | 0 |
| 8 | SellingGeneralAndAdministrativeExpense | 19,349,000 |
| 9 | ResearchAndDevelopmentExpense | 34,734,000 |
| 10 | remainder_Expenses | 0 |
| 11 | remainder_Revenues | 7,000,000 |
| 12 | remainder_NetIncome | 351,000 |
| 13 | remainder_ComprehensiveNetIncome | 0 |
| yvar | yval | |
|---|---|---|
| 0 | Assets | 60,766,000 |
| 1 | Liabilities | 15,366,000 |
| 2 | Expenses | 54,083,000 |
| 3 | Revenues | 7,000,000 |
| 4 | StockholdersEquity | 45,400,000 |
| 5 | NetIncome | -46,732,000 |
| 6 | ComprehensiveNetIncome | -46,732,000 |
| 7 | BaseVar | 68,783,000 |
| 8 | EconomicCapitalRatiobeforeLimitedLiability | 1.37 |
| 9 | EconomicCapitalRatio | 2.59 |
Edgar->Model Mapping
Feature Distribution
Change over Time
